M’rashtra: FDA cancels Johnson & Johnson's licence to make baby powder

Story by  ATV | Posted by  Nakul Shivani • 1 Years ago
J&J's baby powder failed FDA's quality check in Maharashtra
J&J's baby powder failed FDA's quality check in Maharashtra

 

Mumbai

The Maharashtra Food and Drug Administration (FDA) has cancelled the baby talcum powder manufacturing licence of Johnson & Johnson, from its sole plant in the state at Mulund.

The FDA said that the licence was cancelled after samples of the fast-moving Johnson's Baby Powder collected from Nashik and Pune have failed quality checks, and has ordered the company to recall all its stocks from the market.

The powder samples were collected in November 2019, followed by a show-cause notice issued to the company after the FDA report.

The Central Drugs Laboratory in Kolkata confirmed the government analyst's report and issued its final conclusion in the matter after which the FDA swung into action and revoked J&J's licence.

In a statement on its Sepember 15 order, the FDA said: "The product Johnsons Baby Powder is popularly used in new born babies. The sample declared Not of Standard in pH and the use of the product may affect the health of the skin of the new born babies."

ALSO READ: Global economy in its steepest slowdown since 1970: World Bank

Experts, activists and pediatricians have expressed concern over the delay in the FDA licence cancellation order after its first notice to J&J as millions of infants may have used the Johnsons Baby Powder in the intervening period.